Page last updated: 2024-11-05

thiotepa and Corneal Neovascularization

thiotepa has been researched along with Corneal Neovascularization in 2 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Corneal Neovascularization: New blood vessels originating from the corneal blood vessels and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ROCK, RL1
LAVERGNE, G1
COLMANT, IA1

Other Studies

2 other studies available for thiotepa and Corneal Neovascularization

ArticleYear
Inhibition of corneal vascularization by triethylene thiophosphoramide (Thio-Tepa).
    Archives of ophthalmology (Chicago, Ill. : 1960), 1963, Volume: 69

    Topics: Corneal Neovascularization; Corneal Transplantation; Humans; Thiotepa

1963
COMPARATIVE STUDY OF THE ACTION OF THIOTEPA AND TRIAMCINOLONE ON CORNEAL VASCULARIZATION IN RABBITS.
    The British journal of ophthalmology, 1964, Volume: 48

    Topics: Animals; Blood Vessels; Cautery; Cell Division; Cornea; Corneal Neovascularization; Corneal Opacity;

1964